Trial intelligence / Profile preview

Emodepside in Trichuris trichiura and Hookworm infection

NCT05017194Phase 2Completed

Start
Aug 2021
Primary completion
Dec 2021
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of emodepside in trichuriasis and hookworm infection (8 arms). Primary endpoints: Cure Rate against Trichuris trichiura and Cure Rate against Hookworm. Started Aug 2021; status: completed.

02

Drugs

emodepside
03

Conditions

trichuriasishookworm infection

Beyond the preview

Go deeper on NCT05017194.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05017194.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call